Stirling, UK – 29 August 2025 – Symbiosis Pharmaceutical Services (Symbiosis), a global contract manufacturing organisation (CMO) specialising in the sterile manufacture of injectable drug products, has appointed Wendy Cook as a Qualified Person (QP) to further strengthen its regulatory and quality leadership team.

Wendy brings more than 20 years of pharmaceutical quality assurance experience across GLP, GCP and GMP environments, with experience in sterile manufacturing and clinical trial supply chains. Since qualifying as a QP in 2018, she has held roles at both CDMOs and global CMOs, where she oversaw batch certification, regulatory submissions and quality oversight across multiple dosage forms including sterile injectables.

Commenting on her appointment, Wendy said: “Symbiosis has built a reputation for excellence in sterile manufacturing and regulatory compliance. I look forward to supporting clients in bringing their innovative therapies to patients quickly, safely and in full compliance with GMP.”

The appointment follows Symbiosis’ successful MHRA inspection of its new 20,000 sq ft GMP facility, which recently added a state-of-the-art automated sterile fill/finish line to the company’s commercial capabilities. This latest regulatory milestone reinforces Symbiosis’ robust compliance track record with both the MHRA and FDA.

Nicola Paterson, Lead QP at Symbiosis, said: “Wendy’s appointment strengthens our QP team at a pivotal time for Symbiosis. Her knowledge of GMP, regulatory expectations and sterile manufacturing adds significant expertise to our quality leadership. Combined with our recent regulatory approvals,  Wendy’s arrival underlines our commitment to delivering world-class regulatory support and compliant, flexible access to sterile manufacturing capacity for our clients"

By expanding its QP and quality leadership team, Symbiosis continues to enhance its ability to help global biopharmaceutical companies navigate complex regulatory requirements while ensuring the reliable, timely delivery of life-saving injectable therapies.

ENDS

About Symbiosis Pharmaceutical Services:

Symbiosis Pharmaceutical Services (Symbiosis) is a world-class Contract Manufacturing Organisation (CMO) located in Stirling, UK, and is a specialist sterile GMP manufacturer of biopharmaceuticals for use in clinical trials and commercial sales globally. Symbiosis is MHRA-licensed and FDA-inspected and offers a range of services including the aseptic fill/finish of medicines into vials, analytical testing, QP release of product, inspection, labelling, packaging and GMP temperature-controlled storage and shipment of medicines. 

The Symbiosis facilities in Stirling, Scotland, were designed for biologic and small molecule pharmaceutical production to support biotechnology and pharmaceutical companies worldwide requiring sterile injectable pharmaceutical products manufactured in short timeframes for clinical trial use and commercial supply.

Regulatory compliance, technical capability and operational flexibility are core to the Symbiosis value proposition along with direct access to a highly experienced team of life science experts. By adding value directly to the new drug development projects and the commercial manufacturing supply chain requirements of its clients, Symbiosis has demonstrated consistent annual growth and built long-term relationships with its client base globally.

For more information on Symbiosis visit http://www.symbiosis-pharma.com or follow us on LinkedIn.

Media Contact:
Rachael Heath
ramarketing
rachael@ramarketingpr.com
www.ramarketingpr.com